InvestorsHub Logo

Bill B

02/08/21 7:49 AM

#353301 RE: greenJack #353300

Sustaining a higher stock price might be difficult because it will be some months before the FDA approves the drug. A reverse split on good news will ensure the stock price stays high enough to qualify for listing. I believe there are restrictions on some institutional investors buying stock below $5 as well.

Basin Street Blues

02/08/21 7:51 AM

#353303 RE: greenJack #353300

higher the price , the more attractive to tutes and less to retail